Cargando…

Therapeutic role of memantine for the prevention of cognitive decline in cancer patients with brain metastasis receiving whole-brain radiotherapy: a narrative review

Brain metastases are the most common central nervous system tumors. The mainstay treatment for this tumor in low to middle income countries is whole brain radiation therapy. Irreversible cognitive decline is associated with the use of whole brain radiotherapy. Several pharmacologic and nonpharmacolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folloso, Melmar Cerilo, Torres, Mazelle, Ciocon, Stephen Lowell, Ong, Jed Noel, Flores, Jerickson Abbie, Catindig, Joseree-Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762383/ https://www.ncbi.nlm.nih.gov/pubmed/36619840 http://dx.doi.org/10.1590/1980-5764-DN-2021-0102

Ejemplares similares

Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative Review
por: Scampoli, Claudia, et al.
Publicado: (2022)

Memantine for Mitigation of Neurocognitive Toxicity Following Radiation to the Brain
por: Cunningham, Danielle A., et al.
Publicado: (2021)

A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy
por: Wong, Philip, et al.
Publicado: (2016)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Memantine can protect against inflammation-based cognitive decline in geriatric depression
por: Van Dyk, Kathleen, et al.
Publicado: (2020)

Memantine Modulates Oxidative Stress in the Rat Brain following Experimental Autoimmune Encephalomyelitis
por: Dąbrowska-Bouta, Beata, et al.
Publicado: (2021)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Memantine for Prevention of Brain Irradiation–Induced Cognitive Toxicity: A Tale of an Underappreciated and Underused Intervention
por: Chilukuri, Srinivas, et al.
Publicado: (2020)

Memantine increases the dendritic complexity of hippocampal young neurons in the juvenile brain after cranial irradiation
por: Zisiadis, Georgios Alkis, et al.
Publicado: (2023)

Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
por: Atri, Alireza, et al.
Publicado: (2013)

Memantine Protects From Exacerbation of Ischemic Stroke and Blood Brain Barrier Disruption in Mild But Not Severe Hyperhomocysteinemia
por: Gu, Sean X., et al.
Publicado: (2020)

The effects of memantine on prepulse inhibition
por: Swerdlow, NR, et al.
Publicado: (2009)

Pharmacokinetics of memantine in rats and mice
por: Beconi, Maria G., et al.
Publicado: (2012)

Memantine Ameliorates Migraine Headache
por: Shanmugam, Sundar, et al.
Publicado: (2019)

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis
por: Kennedy, Richard E., et al.
Publicado: (2018)

Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole Brain Radiation Therapy
por: Jairam, Vikram, et al.
Publicado: (2022)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil
por: Kano, Osamu, et al.
Publicado: (2013)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Memantine as an Augmentation Therapy for Anxiety Disorders
por: Schwartz, Thomas L., et al.
Publicado: (2012)

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

Efficacy of Memantine Hydrochloride in Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Memantine in neurological disorders – schizophrenia and depression
por: Czarnecka, Kamila, et al.
Publicado: (2021)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Awake (18)F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice
por: Miranda, Alan, et al.
Publicado: (2019)

Memantine Improves the Disturbed Glutamine and γ-Amino Butyric Acid Homeostasis in the Brain of Rats Subjected to Experimental Autoimmune Encephalomyelitis
por: Dąbrowska-Bouta, Beata, et al.
Publicado: (2023)

RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM)
por: Tomé, Wolfgang, et al.
Publicado: (2019)

The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes
por: Major, Nicholas, et al.
Publicado: (2022)

Hypertension, Brain Damage and Cognitive Decline
por: Gąsecki, Dariusz, et al.
Publicado: (2013)

Multiparity, Brain Atrophy, and Cognitive Decline
por: Jung, Joon Hyung, et al.
Publicado: (2020)

The mortality of patients with Parkinson's disease with deep brain stimulation
por: Kim, Ahro, et al.
Publicado: (2023)

Is memantine a potential therapeutic for Rett syndrome?
por: Bello, Olivia, et al.
Publicado: (2013)

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
por: Majláth, Zsófia, et al.
Publicado: (2016)

Crystal structure of memantine–carboxyborane
por: Ayudhya, Theppawut I., et al.
Publicado: (2019)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline—Does Insulin Have Anything to Do with It? A Narrative Review
por: Rebelos, Eleni, et al.
Publicado: (2021)

Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
por: Koola, Maju Mathew, et al.
Publicado: (2018)

NCOG-24. WAKE FOREST NCORP RESEARCH BASE FEASIBILITY STUDY OF RAMIPRIL FOR PREVENTING COGNITIVE DECLINE IN GLIOBLASTOMA PATIENTS RECEIVING BRAIN RADIOTHERAPY (WF-1801)
por: Cramer, Christina, et al.
Publicado: (2020)

Changes of Brain Functional Connectivity in End-Stage Renal Disease Patients Receiving Peritoneal Dialysis Without Cognitive Decline
por: Chang, Ting-Yu, et al.
Publicado: (2021)

Development of Clinical Milestones in Parkinson’s Disease After Bilateral Subthalamic Deep Brain Stimulation
por: Ong, Jed Noel A., et al.
Publicado: (2022)

Treatment with Piribedil and Memantine Reduces Noise-Induced Loss of Inner Hair Cell Synaptic Ribbons
por: Altschuler, Richard A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t7oupdujlsjsrs4jnpictqp5ue